JP2025521508A5 - - Google Patents

Info

Publication number
JP2025521508A5
JP2025521508A5 JP2024574640A JP2024574640A JP2025521508A5 JP 2025521508 A5 JP2025521508 A5 JP 2025521508A5 JP 2024574640 A JP2024574640 A JP 2024574640A JP 2024574640 A JP2024574640 A JP 2024574640A JP 2025521508 A5 JP2025521508 A5 JP 2025521508A5
Authority
JP
Japan
Prior art keywords
alkyl
unsubstituted
compound according
substituted
halogens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024574640A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025521508A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/025389 external-priority patent/WO2023249875A1/en
Publication of JP2025521508A publication Critical patent/JP2025521508A/ja
Publication of JP2025521508A5 publication Critical patent/JP2025521508A5/ja
Pending legal-status Critical Current

Links

JP2024574640A 2022-06-21 2023-06-15 置換ピロリジニル及びピペリジニル化合物並びに関連する治療方法 Pending JP2025521508A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263353985P 2022-06-21 2022-06-21
US63/353,985 2022-06-21
PCT/US2023/025389 WO2023249875A1 (en) 2022-06-21 2023-06-15 Substituted pyrrolidinyl and piperidinyl compounds and related methods of treatment

Publications (2)

Publication Number Publication Date
JP2025521508A JP2025521508A (ja) 2025-07-10
JP2025521508A5 true JP2025521508A5 (https=) 2026-04-27

Family

ID=89380500

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024574640A Pending JP2025521508A (ja) 2022-06-21 2023-06-15 置換ピロリジニル及びピペリジニル化合物並びに関連する治療方法

Country Status (7)

Country Link
US (1) US20250223260A1 (https=)
EP (1) EP4543435A1 (https=)
JP (1) JP2025521508A (https=)
CN (1) CN119730848A (https=)
AU (1) AU2023287589A1 (https=)
CA (1) CA3260217A1 (https=)
WO (1) WO2023249875A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202547460A (zh) * 2024-04-04 2025-12-16 日商橘生藥品工業股份有限公司 取代磺醯胺化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1272467A4 (en) * 2000-04-06 2003-05-07 Merck Frosst Canada Inc Cathepsin cysteine protease inhibitors
CA2583983C (en) * 2004-10-14 2013-07-16 Abbott Gmbh & Co. Kg Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
BRPI1014583B1 (pt) * 2009-06-26 2020-03-31 Pfizer, Inc. Sulfonamidas heterocíclicas e composições farmacêuticas
US20200207734A1 (en) * 2017-08-03 2020-07-02 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
KR101953300B1 (ko) * 2018-06-22 2019-02-28 의료법인 성광의료재단 탁산계 항암제 내성 암의 진단 및 치료를 위한 조성물, 키트 및 방법

Similar Documents

Publication Publication Date Title
JP2023554282A5 (https=)
JP2024501641A5 (https=)
JP2022510313A5 (https=)
JP2022185107A5 (https=)
JP2021183609A5 (https=)
JP2020533352A5 (https=)
JP2024516633A5 (https=)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2001526223A5 (https=)
JP2016534134A5 (https=)
JP2023539194A5 (https=)
JP2021531234A5 (https=)
RU2017121906A (ru) Конъюгаты цистеамина и жирной кислоты и их применение в качестве активаторов аутофагии
JP2015517574A5 (https=)
JP2018522823A5 (https=)
JP2025521508A5 (https=)
JP2005514420A5 (https=)
JP2022549222A5 (https=)
JP2025521503A5 (https=)
JP2021535159A5 (https=)
JP2018528942A5 (https=)
JP2025503448A5 (https=)
JPWO2023195529A5 (https=)
JP2021524482A5 (https=)
JP2020111571A5 (https=)